AIM BREAKFAST – 25th August 2016
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 1,005
Total number of AIM Companies trading: 991*
* As at 24 August 2016
Dish of the Day:
No primary today
No primary today
Off the Menu:
No leavers today
No leavers today
Set Menu ISDX Growth:
Total number of ISDX Growth Market Companies (Incl Susp): *
Total number of ISDX Growth Market Companies trading: *
* As at 24 August 2016
Dish of the Day:
Off the Menu:
What’s Cooking in the IPO Kitchen?
APQ Global – The lendor recently raised £78m on admission to the Channel Islands Security Exchange and is joining AIM tomorrow
Misys— The press reports that the Banking Technology provider owned by Vista Equity Partners is seeking a £5.5bn float in London
Bacanora Lithium— To list on AIM around 28 Sep as holding company for TSX listed Bacanora Minerals at £100m market cap
Aura Energy—ASX listed uranium developer (ASX:AEE) expected to join AIM 6 September
OptiBiotix Health* (OPTI.L) 74p £57.8m
The Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, has today released its Half Year report to May 2016 highlighting a period of accelerating commercial and scientific progress. The period included agreements with major food brands and ingredients manufacturers, the formation of a JV based around its IP in the skin Microbiome and a placing of £1m at 78p. Opti now has four divisions each of which have the potential for a separate listing.
Vitesse Media (VIS.L) 4.25p £2.74m
The B2B events and digital media company has reported H1Jul16 results. Revenues increased by 12.5% to £931k. Losses reduced by 45% to £69k.· Major overhaul of all brand websites to be launched by the end of September 2016.
“Women in IT” revenues significantly increased over the prior year. In only its third year 650 attendees, are expected up from 450 last year. Funding remains tight with net current liabilities of £0.5m.
Wey Education (WEY.L) 3.62p £3.47m
FYAUG16 trading update from the education group operating InterHigh, the UK’s only online fee paying secondary school teaching iGCSEs and A-Levels.
2015/16 student numbers at record levels – up 52% year on year· Second School launched in August 2016. New intensive A-Level retake course launched from September 2016. The Company expects to make its Preliminary Announcement on 31 October 2016.
Thor Mining (THR.L) 0.03p £1.86m
The Company has announced the commencement of the aircore drilling campaign designed to test for additional tungsten mineralisation within a six kilometre radius of the Company’s existing Molyhil tungsten deposit in the Northern Territory of Australia. 50 hole drill programme designed to test bedrock through shallow alluvial cover. The key objective of the new drilling programme is to find additional ore sources for the Molyhil project, thereby extending the estimated mine life and reducing costs.
Hayward Tyler Group (HAYT.L) 86.5p £47.91m
The specialist engineering group announced the official opening by the Duke and Duchess of Cambridge of its Centre of Excellence. The new “fit-for-nuclear” facility in Luton, recently underwent a multimillion pound refurbishment which will support the Group’s long-term growth plans across its international markets.
The Centre of Excellence is now the world’s most advanced facility for specialist fluid-filled motor manufacturing.
Cyprotex (CRX.L) 145.5p £32.7m
The specialist Contract Research Organisation (CRO), announced the installation of two AB Sciex TripleTOF® 6600 mass spectrometer systems complementing its existing offer. “As we expand into new markets, our analytical capabilities need to diversify to meet the requirements for different types of molecules. Cyprotex now have an impressive range of analytical separation and detection capabilities enabling us to tackle more challenging molecules with the greatest chance of success.”
Bellzone Mining (BZM.L) 0.3p £4.38m
Bellzone has announce an update and results of the technical study undertaken to date on its Kalia Project for the production of ferronickel, as the first step in exploiting its Kalia iron ore concession: A further detailed study to determine the major cost parameters for a base case ferronickel project indicates a financially attractive opportunity. The planned Ferronickel Project production is supported by Indicated and Inferred Mineral Resources of 79.28 million tonnes at 0.69% .
MXC Capital (MXCP.L) 2.9p £99.16m
The Company returned £0.8 million to shareholders in the February 2016 Tender Offer and the Board now proposes to return a further £3 million to shareholders via a Tender Offer at 3.6 pence per share, a premium of 24% over the closing middle market price at 24 August 2016. The Technology focused merchant bank is trading well, and made a £7m realisation of part of its investment in Redcentric in June. The estimated post tender offer cash balance is £12m.
Coral Products (CRU.L)21 p £17.35m
FYApr16 finals from the specialist in design, manufacture and supply of injection moulded plastic products. Group revenue increase of 7.4% to £18.7m. Underlying EBITDA increased by 22.5% to £2.3m maintaining an improvement in operating cash flow. Successful integration of business and assets from Neiman Packaging Limited in June 2015. The shares are on a current year PE of 6.9x and projected yield of 6.8%.
Taihua (TAIH.L) 1.13p £0.92m
The Company is a pharmaceutical company based in China that specialises in the cultivation of raw materials that are used in Traditional Chinese Medicine along with the manufacture of TCM and Homoharringtonine. It has launched an Open Offer to raise £716k at 2.63, a premium of 133.8% to complete a share buy back. We are a little puzzled by this transaction.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.